Your Article Summary
See Latest ArticlesMelatonin as a potential therapeutic agent in psychiatric illness
Human Psychopharmacology: Clinical and Experimental, 07/01/09
Maldonado MD et al. - The pathogenesis of mental disorders remains ambiguous and neuroinflammation has been proposed as a causative agent. This study considers the potential contributions of melatonin as therapeutic agent in CNS and during neuroinflammation in mental disorders.
Today in Psychiatry...keeping you current
Receive free subspecialty "5-minute updates" via email
An algorithm for the pharmacological treatment of depression
Acta Psychiatrica Scandinavica, 11/04/09
Is Monotherapy as Good as Polypharmacy in Long-Term Treatment of Bipolar Disorder
Canadian Journal of Psychiatry, 11/16/09
Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
JAMA, 10/28/09